Deep rTMS in Parkinson Disease Pain Syndromes
Unknown statusNot applicableNCT03504748
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Pain is the most prevalent non-motor symptom in Parkinson disease, and the motor improvement not always is related to the pain improvement with the medication treatment. By this, we are testing a non-invasive method called transcranial magnetic stimulation as an alternative to treat pain related to Parkinson disease. This technique can lead to either inhibitory or excitatory effects in brain circuits depending on stimulation parameters, and is known to provide analgesic effects.
Study details
- Official title
- Deep rTMS in Parkinson Disease Pain Syndromes
- Conditions
- Interventions
- Device: deep rTMS
- Device: placebo deep rTMS
- Sponsor
- University of Sao Paulo
- Start date
- 2015-07-20
- Primary completion
- 2018-07
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Parkinson disease * Signed term of informed consent * Parkinsson disease related pain Exclusion Criteria: * Trauma of Skull, epilepsy don't treated * Use of medications decrease the seizure threshold * Patients in use of drugs, how cocaine and alcohol * neurosurgical clips, pacemakers, increased intracranial pressure (risk of sequelae after seizure) * Pregnant or lacting women * Moderate or severe cognitive impairment
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03504748